Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients
Clinical trial NCT00865579 · TERMINATED
Trial details
- NCT number
- NCT00865579
- Sponsor
- Newron Pharmaceuticals SPA
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2012-06-01
- Enrollment
- 964
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.